MedPath

Withdrawal Exposure With Withdrawal Regulation Training for Smoking Cessation

Not Applicable
Completed
Conditions
Smoking Cessation
Interventions
Behavioral: Relaxation training
Behavioral: Withdrawal regulation training
Registration Number
NCT02192762
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

This is a pilot study of a withdrawal regulation training program compared to relaxation training for individuals that are interested in smoking cessation.

Detailed Description

Participants will be recruited through newspaper and internet advertisements, advertisements on public transportation, community centers and community based organizations. All recruitment materials will contain a toll-free telephone number with 24-hour voice mail. The first contact with potential participant will be by telephone interview to assess for eligibility of participant. Participants who meet eligibility criteria will be invited to an orientation meeting where a breath carbon monoxide sample will be obtained. Women participant of childbearing potential will have a pregnancy test administered.

Participants will be randomized to one of two conditions: Early Withdrawal Exposure + Withdrawal Relaxation Training (E+WT) or Relaxation Training (RT) control. The E+WT condition will consist of the development, application, modification, and repeated practice of individualized withdrawal regulation for behavioral and cognitive strategies. the RT condition will control for the therapeutic contact received by those in the E+WT condition and will consist of the development, application, modification, and repeated practice of individualized relaxation techniques (e.g. breathing exercises, imagery).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Men and women at least 19 years of age
  • Reports smoking at least 10 cigarettes per day
  • Must have expired breath carbon monoxide reading of at least eight parts per million
  • Report the intention to quit smoking
  • Reside in the Birmingham area with no plan to relocate outside of the area in the next six months
  • Have access to a telephone for scheduling follow up assessments
Read More
Exclusion Criteria
  • Inability to speak English
  • Presence of a condition that contraindicates use of transdermal nicotine patch (i.e. angina pectoris, arrhythmia, recent myocardial infarction, allergies to adhesives, serious skin disorders, and current pregnancy or breast feeding)
  • Presence of conditions that might interfere with compliance with protocol or greatly complicate treatment (i.e. current alcohol or other substance dependence, dementia, psychosis, schizophrenia, bipolar disorder, suicidal or homicidal ideation, and any disease acutely life-threatening or so severe that the participant cannot comply with the protocol)
  • Concurrent participation in a formal treatment program for smoking cessation
  • Current use of any pharmacotherapy for smoking cessation
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Relaxation trainingRelaxation trainingRelaxation skills instruction
Withdrawal regulation trainingWithdrawal regulation trainingWithdrawal coping skills
Primary Outcome Measures
NameTimeMethod
Biochemically-verified smoking abstinence3 months after end-of-treatment

Smoking abstinence will be determined by self-report and confirmed via breath carbon monoxide (CO) analysis. Self-report of no smoking over the past 7 days (7-day point prevalence abstinence) and a CO value of less than 8 parts per million will be indicative of smoking abstinence. Self-report of any smoking over the past 7 days and/or CO values of 8 or greater will be indicative of cigarette use.

Biochemically verified smoking abstinence2 months after end-of-treatment

Smoking abstinence will be determined by self-report and confirmed via breath carbon monoxide (CO) analysis. Self-report of no smoking over the past 7 days (7-day point prevalence abstinence) and a CO value of less than 8 parts per million will be indicative of smoking abstinence. Self-report of any smoking over the past 7 days and/or CO values of 8 or greater will be indicative of cigarette use.

Secondary Outcome Measures
NameTimeMethod
Withdrawal symptoms3 months after end-of-treament

Withdrawal symptoms will be measured via self-report with the Wisconsin Smoking Withdrawal Scale (WSWS), a reliable and valid instrument of smoking withdrawal symptomatology.

Trial Locations

Locations (1)

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath